Skip to search formSkip to main contentSkip to account menu

oritavancin 400 MG Injection

Known as: ORITAVANCIN 400MG/VIL INJ, ORITAVANCIN 400MG/VIL INJ [VA Product], oritavancin (as oritavancin diphosphate) 400 MG Injection 
National Institutes of Health

Related topics

Related topics

5 relations
Anti-Bacterial AgentsBacterial InfectionsInjectionLipoglycopeptides [Chemical/Ingredient]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Inhibition of d-Ala incorporation into wall teichoic acid in Staphylococcus aureus by desleucyl-oritavancin.
The mode of action for desleucyl-oritavancin was investigated by adding an antibiotic to Staphylococcus aureus during its growth… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)